Premium
Oric Pharmaceuticals Inc (ORIC)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Nextech Invest Ltd. | Institution | 7 162 637 | 6,92% | US$ 57,44M | 2026-03-31 |
| Nextech Crossover I SCSP | Institution | 7 162 637 | 6,92% | US$ 57,44M | 2025-06-30 |
| EcoR1 Capital, LLC | Institution | 6 728 116 | 6,50% | US$ 53,96M | 2026-03-31 |
| Ecor1 Capital Fund Qualified, L.P. | Institution | 6 283 426 | 6,07% | US$ 50,39M | 2025-07-29 |
| BlackRock, Inc. | Institution | 5 984 552 | 5,78% | US$ 48,00M | 2026-03-31 |
| Viking Global Investors LP | Institution | 5 824 533 | 5,63% | US$ 46,71M | 2026-03-31 |
| T. Rowe Price Group, Inc. | Institution | 5 387 783 | 5,20% | US$ 43,21M | 2026-03-31 |
| SR One Capital Management, LP | Institution | 4 514 929 | 4,36% | US$ 36,21M | 2026-03-31 |
| VR Management, LLC | Institution | 4 319 765 | 4,17% | US$ 34,64M | 2026-03-31 |
| New Enterprise Associates, Inc. | Institution | 4 118 621 | 3,98% | US$ 33,03M | 2026-03-31 |
| Alkeon Capital Management, LLC | Institution | 3 751 818 | 3,62% | US$ 30,09M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 3 702 196 | 3,58% | US$ 29,69M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 3 687 007 | 3,56% | US$ 29,57M | 2026-03-31 |
| Column Group Venture Partners II, L.P. | Institution | 3 540 777 | 3,42% | US$ 28,40M | 2024-09-30 |
| The Column Group, LLC | Institution | 3 540 777 | 3,42% | US$ 28,40M | 2026-03-31 |
| Pfizer Venture Investments LLC | Institution | 3 442 940 | 3,33% | US$ 27,61M | 2026-03-31 |
| Venrock Healthcare Capital Partners EG, L.P. | Institution | 3 415 564 | 3,30% | US$ 27,39M | 2026-03-31 |
| OrbiMed Advisors LLC | Institution | 2 693 929 | 2,60% | US$ 21,61M | 2026-03-31 |
| AIHC Capital Management Limited | Institution | 2 459 551 | 2,38% | US$ 19,73M | 2026-03-31 |
| FMR LLC | Institution | 2 434 080 | 2,35% | US$ 19,52M | 2026-03-31 |
| Citadel Advisors LLC | Institution | 2 422 741 | 2,34% | US$ 19,43M | 2026-03-31 |
| SR One Capital Opportunities Fund I, LP | Institution | 2 330 218 | 2,25% | US$ 18,69M | 2025-08-12 |
| First Turn Management, LLC | Institution | 2 017 284 | 1,95% | US$ 16,18M | 2026-03-31 |
| Artal Group S.A. | Institution | 1 990 617 | 1,92% | US$ 15,96M | 2026-03-31 |
| Vivo Capital, LLC | Institution | 1 848 786 | 1,79% | US$ 14,83M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 1 838 801 | 1,78% | US$ 14,75M | 2026-03-31 |
| MPM BioImpact LLC | Institution | 1 803 945 | 1,74% | US$ 14,47M | 2026-03-31 |
| Paradigm Biocapital Advisors LP | Institution | 1 701 217 | 1,64% | US$ 13,64M | 2026-03-31 |
| Morgan Stanley | Institution | 1 665 288 | 1,61% | US$ 13,36M | 2026-03-31 |
| Dimensional Fund Advisors LP | Institution | 1 471 290 | 1,42% | US$ 11,80M | 2026-03-31 |
| Franklin Resources, Inc. | Institution | 1 452 705 | 1,40% | US$ 11,65M | 2026-03-31 |
| Integral Health Asset Management, LLC | Institution | 1 400 000 | 1,35% | US$ 11,23M | 2026-03-31 |
| Woodline Partners LP | Institution | 1 247 515 | 1,21% | US$ 10,01M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 1 215 827 | 1,17% | US$ 9,75M | 2026-03-31 |
| Royce & Associates, LP | Institution | 1 207 223 | 1,17% | US$ 9,68M | 2026-03-31 |
| Braidwell LP | Institution | 1 128 040 | 1,09% | US$ 9,05M | 2026-03-31 |
| Silverarc Capital Management, LLC | Institution | 1 100 010 | 1,06% | US$ 8,82M | 2026-03-31 |
| Bank of America Corporation | Institution | 1 043 159 | 1,01% | US$ 8,37M | 2026-03-31 |
| Invus Financial Advisors, LLC | Institution | 1 007 575 | 0,97% | US$ 8,08M | 2026-03-31 |
| Euclidean Capital LLC | Institution | 989 410 | 0,96% | US$ 7,94M | 2026-03-31 |
| ArrowMark Colorado Holdings, LLC | Institution | 960 517 | 0,93% | US$ 7,70M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
